BMO Harris Supports Bio-Techne Acquisition of Advanced Cell Diagnostics
Bio-Techne completed its acquisition of Advanced Cell Diagnostics. This represents the ninth acquisition for Bio-Techne in the last three years. BMO Harris Bank agented a $400 million credit facility to support the transaction.
August 3, 2016
Bio-Techne | BMO Harris Bank | J.P. Morgan Securities | PNC
ABF Journal